The nation of Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) over five years because of Washington's insistence on sensitive biological samples.
The decision came to light following a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman has since clarified that the United States was seeking genetic material for research and commercial gain but refused to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more dialogue to reach a agreement agreeable to all parties so the country's vital HIV programme can be sustained.
Wider Context
This rejection follows a similar situation in Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research with no certainty that the final treatments would be accessible to our people if a future disease outbreak arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining frameworks already set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome ongoing dialogue with our US partners on how subsequent co-operation might be arranged in a manner that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but suggested that talks need to persist since a large portion of the country's HIV programmes relied on foreign aid.
"In cases where technical issues exist, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.
The situation emphasises the ongoing challenges between accepting crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.